Merit Medical to Participate at the J.P. Morgan Healthcare Conference
Merit Medical (NASDAQ: MMSI) will participate in the 44th Annual J.P.
Rhea-AI Summary
Merit Medical (NASDAQ: MMSI) will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, January 12-15, 2026. Management will present a company overview on Tuesday, January 13, 2026 at 4:30 PM PT / 7:30 PM ET.
Martha G. Aronson, President and CEO, and Raul Parra, CFO, will deliver the presentation. A live audio webcast will be accessible via Merit’s investor relations "Events" page, and presentation materials will be posted to Merit’s investor relations "Investor Events and Presentations" page. A replay will be available on the site for approximately 90 days.
Positive
- None.
Negative
- None.
Details
News Market Reaction – MMSI
On Dec 23, the day this news came out, MMSI closed 0.33% below the previous close.
Data tracked by StockTitan Argus for the Dec 23 session.
Key Figures
- Conference edition
- 44th Annual
- J.P. Morgan Healthcare Conference participation
- Conference dates
- January 12–15, 2026
- J.P. Morgan Healthcare Conference schedule
- Presentation time
- 4:30 pm PT / 7:30 pm ET
- Company overview presentation slot on January 13
- Replay duration
- 90 days
- Webcast replay availability on investor relations site
- Year founded
- 1987
- Founding year of Merit Medical Systems
- Sales & clinical team
- 800+ individuals
- Domestic and international sales force and clinical support team
- Employees
- Approximately 7,400
- Global workforce size
Historical Context
-
CMS deferral but start of full U.S. commercialization and reiterated WRAPSODY forecast.
-
WAVE trial AVF arm showed superior 24‑month patency vs. PTA in hemodialysis patients.
-
Non‑randomized AVG cohort met patency performance goals with strong 6–24 month outcomes.
-
Q3 2025 revenue growth, margin improvement, and raised 2025 revenue and EPS guidance.
-
Agreement to acquire C2 CryoBalloon technology with expected future revenue contribution.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SOUTH JORDAN, Utah, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that management will participate in the 44th Annual J.P. Morgan Healthcare Conference, which is being held at The Westin St. Francis Hotel in San Francisco, California, January 12-15, 2026. To learn more, visit Healthcare Conference.
Martha G. Aronson, President and Chief Executive Officer, and Raul Parra, Chief Financial Officer, will present a company overview and update on Tuesday, January 13th at 4:30 pm Pacific Time / 7:30 pm Eastern Time.
Presentation materials for the conference will be posted to Merit’s investor relations website, Investor Events and Presentations - Merit Medical. A live audio webcast of the presentation will be accessible under the “Events” section of Merit’s investor relations website at Investor Events and Presentations - Merit Medical. A replay of the presentation will be available on this same website for approximately 90 days.
ABOUT MERIT MEDICAL
Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,400 people worldwide.
CONTACTS
PR/Media Inquiries
Sarah Comstock
Merit Medical Systems, Inc.
+1-801-432-2864 | sarah.comstock@merit.com
Investor Inquiries
Mike Piccinino, CFA, IRC
Westwicke - ICR
+1-443-213-0509 | mike.piccinino@icrhealthcare.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.